Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-25 @ 4:32 AM
NCT ID:
NCT00153218
Eligibility Criteria:
Inclusion Criteria:
* patients must have metastatic breast cancer
* tumor must have been determined to be Her-2 positive 3+ by immunohistochemistry or gene-amplified by fluorescence-in-situ hybridization (FISH)
* must have received trastuzumab alone or in combination with chemotherapy or hormonal therapy
* must not have received trastuzumab in the adjuvant or neoadjuvant setting
* must have started trastuzumab treatment for metastatic disease any time between January 1996 to June 2003
Exclusion Criteria:
* patients who received trastuzumab prior to 1996
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT00153218
Study Brief:
Protocol Section:
NCT00153218